CTCs from patients with CRPC have specialized markers

A team of researchers at Duke University have shown that most men with castration-resistant prostate cancer (mCRPC) express multiple epithelial proteins in their circulating T cells (CTCs). … READ MORE …

The prostate cancer news update: Friday, October 10

Today’s news includes information about:

  • A review of the risk associated with testosterone therapy in men with low testosterone levels
  • Issues related to stress and coping among couples dealing with prostate cancer
  • The pivotal trial leading to approval of circulating T-cell counts as a means to evaluate treatment of men with very late-stage prostate cancer … READ MORE …